|
| Exchange Received Time 20/09/2017 10:33:51 Exchange Disseminated Time 20/09/2017 10:33:55 Time Taken 00:00:04 | We wish to inform that Divi's Laboratories Limited, Unit-2 has been inspected by US-FDA from September 11 to September 19, 2017.
This inspection was for full cGMP and verification of all Corrective Actions proposed against the previous Inspection observations. Divi's Laboratories Limited announces that all previous observations have been confirmed as completed and resolved.
On completion of this inspection, Divi's Laboratories Limited has received a Form 483 citing six observations which are procedural and the company will be responding to these within the stipulated time.
Disclaimer:
This is to inform that the statements in this document relating to the estimates or events may be 'forward looking statements' within the meaning of the applicable securities regulations. Actual results, performance or events, financial or non-financial, could differ materially from those expressed or implied.
|
|
|